What Sulfato Ferroso-Roxfarma Treats: Main Uses and Benefits

The primary therapeutic use of the active ingredient, ferrous sulfate (or sulfato ferroso), is to manage conditions involving episodic or fluctuating manifestations related to iron deficiency. It is relevant when supportive symptom management is appropriate for conditions marked by low levels of red blood cells, which commonly presents as iron deficiency anemia.

This medicine is considered relevant for easing symptoms related to physical discomfort, systemic imbalance, and those that interfere with daily functioning, such as fatigue, headache, and dizziness. Ferrous sulfate is a type of iron supplement that may assist with managing or preventing this condition.

The treatment supports the patient during difficult episodes by easing distress and contributes to improved comfort during periods of heightened symptoms. It is applied across domains where additional symptomatic support is needed.

Quick Fact: Relief for Symptom Clusters Softening Modifier: May

“The supportive effect of iron therapy plays a role in managing symptoms related to systemic imbalance and maintaining functional stability during symptomatic periods.”

Regulatory References

1. NIH MedlinePlus overview on Iron Deficiency Anemia

Who Can and Cannot Use Sulfato Ferroso-Roxfarma?

This information on eligibility is derived strictly from official government regulatory documents (e.g., FDA, EMA) and defines the populations that may and must not use this medicine.

Populations for Whom Use is Restricted or Contraindicated

Official labeling establishes several contraindications, meaning the drug must not be used in the following populations due to specific health risks:

• Iron Overload Syndromes: Individuals with established iron storage diseases, such as hemochromatosis or hemosiderosis, are contraindicated as this medicine may exacerbate the condition.
• Specific Gastrointestinal (GI) Diseases: Patients with certain severe GI pathologies, including active peptic ulceration, ulcerative colitis, or regional enteritis, are excluded from use.
• Repeated Blood Transfusions: Use is contraindicated for patients who are to receive repeated blood transfusions.
• Hypersensitivity: Those with a known hypersensitivity to ferrous salts (the active ingredient) or any component of the formulation.
• Non-Iron Deficiency Anemias: It is contraindicated for patients with hemolytic anemia or other anemias not caused by iron deficiency, unless iron deficiency is confirmed to be concurrently present.

General Eligibility

Sulfato Ferroso-Roxfarma is indicated for use in adults and children for the prevention and treatment of iron deficiency, provided none of the above contraindications are present. The official documentation confirms eligibility for use during pregnancy and lactation where there is a documented need for iron supplementation.

Sulfato Ferroso-Roxfarma Interactions with other medicines and products

Ferrous Sulfate, the active ingredient in this medicine, is officially documented to interact with various substances primarily by reducing oral absorption in the gastrointestinal tract due to complex formation. This pharmacokinetic interaction can decrease the plasma concentration and, consequently, the effectiveness of the co-administered drug.

Officially documented interactions necessitate strict separation of administration times to minimize this binding effect, as detailed in regulatory prescribing information.

Interacting Product Category	Effect and Official Requirement
Tetracycline & Quinolone Antibiotics	Reduced absorption of the antibiotic. Requires administration to be separated by specific time intervals.
Levothyroxine (Thyroid Hormone)	Reduced absorption of the hormone. Mandatory separation of administration, typically by at least two hours.
Bisphosphonates & Levodopa	Reduced absorption of these medicines. Strict time separation is required to maintain their efficacy.
Antacids, Calcium/Zinc Supplements	Reduced absorption of Ferrous Sulfate itself. Administration must be separated by at least one to two hours.
Foods/Beverages	Specific items like coffee, tea, milk, and certain whole grains may impair iron absorption and should be avoided when taking the dose.

Regulatory documents stipulate that co-administration is restricted or contraindicated in patients with conditions like hemochromatosis, hemosiderosis, or for those receiving repeated blood transfusions.

How Sulfato Ferroso-Roxfarma Works

Sulfato Ferroso-Roxfarma provides the ferrous Fe^2+ ion, which is absorbed and incorporated into systemic iron pools. The primary mechanism begins with the passive diffusion and active transport of Fe^2+ across the brush border membrane of duodenal and proximal jejunal enterocytes via the Divalent Metal Transporter 1 (DMT1).

Once inside the enterocyte, the Fe^2+ is either sequestered by ferritin for storage or transported out of the cell across the basolateral membrane via Ferroportin (FPN). This efflux is coupled with the oxidation of Fe^2+ to Fe^3+ by the membrane-bound ferroxidase, Hephaestin (HEPH). The resulting Fe^3+ is then loaded onto the plasma transport protein, Transferrin (Tf).

This loaded Transferrin circulates, delivering the iron to erythroblast precursors in the bone marrow, facilitating the process of hemoglobin synthesis and is required for iron utilization in erythropoiesis. The Fe^2+ ion is a requisite component for several iron-containing proteins and enzymes.

How to Use Ferrous Sulfate (Sulfato Ferroso) — Administration Guidelines

Ferrous Sulfate is an iron supplement whose usage instructions focus strictly on administration procedures and dosage amounts.

Administration Scope	Standard Instructions
Route of Administration	Oral (swallowed by mouth).
Dosing Schedule	Dosing is based on the elemental iron content. Adult treatment ranges from 100 mg to 200 mg elemental iron per day. Adult prophylaxis is typically 60 mg elemental iron daily.
Age-Group Rules	Pediatric treatment is weight-based, typically 3 mg to 6 mg elemental Fe/kg/day, often divided into 8- or 12-hour intervals. Infants may require prophylaxis starting at 2 or 4 months of age.
Frequency	Standard formulations may be administered once, twice, or three times per day. Extended-release forms are typically administered once daily.
Preparation	Liquid forms (solutions/drops) require careful measurement, as the dose is calculated based on the elemental iron concentration (e.g., 15 mg elemental Fe/mL).

---

Resulting Procedural Structure

The correct use protocol requires calculating the dose based on the elemental iron content for the specific patient and condition (treatment or prophylaxis). The prescribed dose must be administered orally and divided into the required daily frequency (e.g., once daily for extended-release or up to three times daily for standard forms in children). This structure ensures the delivery of the specific amount of iron.

Sulfato Ferroso-Roxfarma: Recent Clinical Evidence

This section reviews key findings from studies investigating the use of ferrous sulfate supplementation, the active component of Sulfato Ferroso-Roxfarma.

Activity and Research Focus

Research has explored the drug's activity related to iron absorption and incorporation into key biological pathways, such as those involving hemoglobin synthesis. Studies examined the drug's interaction within the digestive system, where ferrous iron is converted and absorbed.

Clinical trials have evaluated the drug's effects on pre-defined clinical measures based on endpoints, such as changes in serum ferritin (iron storage) and hemoglobin levels (oxygen-carrying capacity).

Clinical Findings and Symptom Review

Studies have investigated the drug's effects on anemia symptoms over a treatment period, including fatigue and weakness. This research often used standardized patient-reported outcomes to track symptom findings alongside laboratory results.

Data from combined studies has been analyzed to assess whether the drug influenced iron stores and red blood cell parameters compared with placebo or dietary management alone. The research suggests that supplementation may lead to increased hemoglobin levels in individuals with iron deficiency.

Studies evaluated various dose levels of ferrous sulfate to determine the appropriate intake for different deficiency severity levels.

Safety Profile and Tolerability

Research on the safety profile has characterized commonly reported adverse events, primarily those related to the gastrointestinal system, such as nausea, constipation, and abdominal discomfort. Study protocols detailed adverse event collection across different participant groups.

Reported adverse events were typically categorized by severity. A review of studies included adults and, in some cases, children and pregnant individuals; however, specific findings on adverse events should be discussed with a healthcare provider.

Long-Term Follow-up and Quality of Life

Long-term studies have followed participants for periods to monitor the biological response over an extended period and the maintenance of improved iron status. This research investigated whether the effects seen in short-term trials continued or changed after initial correction of the deficiency.

Researchers also examined the drug's effects on patient-reported quality of life measures, particularly those related to energy levels and physical function.

Common questions about Sulfato Ferroso-Roxfarma (FAQ)

---

Q: Should I take this on an empty stomach or with food to make it work better?

Official information generally indicates that this medicine is best absorbed when taken on an empty stomach, typically one hour before or two hours after eating. However, taking the supplement with food is a common strategy mentioned in labeling that may help if you experience an upset stomach or gastrointestinal discomfort.

---

Q: I forgot a dose—what should I do now?

According to official product information, if a dose is missed, official instructions generally state to take it as soon as it is remembered. However, if it is already close to the time for the next scheduled dose, official instructions recommend skipping the missed dose and continuing with the regular schedule. Taking a double dose to compensate for a missed one is not recommended.

---

Q: Will taking the iron supplement make my poop black?

Yes, regulatory documents and product labeling confirm that a change in stool color to dark brown or black is a very common and expected effect of taking oral iron supplements. This is a result of the iron passing through the digestive system and is generally considered harmless.

---

Q: How long does it typically take to see an increase in my energy levels?

Studies and official information often suggest that an improvement in symptoms associated with iron deficiency, such as fatigue and weakness, may begin to be noticeable after approximately three to four weeks of consistent therapy. Full correction and replenishment of the body's iron stores may typically take two to four months.

---

Q: What should I do with my remaining tablets after my treatment is finished?

Official regulatory guidance requires that any unused or expired medicine must be disposed of safely to ensure it is kept out of the sight and reach of children. Official guidance on disposal advises consulting local drug take-back programs or a pharmacist to determine the safest and most appropriate method in your area.

---

Q: Why do I need to take this medicine for several months?

The typical duration of iron supplementation is several months, as outlined in official labeling. This prolonged course is often necessary to not only correct the low circulating iron levels but also to fully replenish the body's iron stores, which is vital for maintaining long-term iron status.

Storage and Disposal Requirements

Official regulatory documentation defines mandatory conditions for storing and disposing of Ferrous Sulfate (Sulfato Ferroso-Roxfarma) to ensure product stability and safety.

Condition Type	Requirement
Temperature	Store at Controlled Room Temperature, typically 20 to 25 C.
Stability	Keep in a cool, dry place, protected from light and moisture and away from excessive heat.
Container	Must be kept in the original container, which should be tightly closed.
Child Safety	Keep out of the sight and reach of children at all times. The product packaging is required to use child-resistant closures.
Disposal	Unused or expired medicine must be disposed of safely in a manner that ensures it cannot be accessed by children. Consult local disposal regulations.